One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
- :
Price : 100$- Special Price : 50$
ECM1: a novel matricellular protein with promising antifibrotic potential
doi : 10.1136/gutjnl-2024-333455
March 2025 - Volume 74 - 3
Quest for HBV functional cure: what have we learnt from silencing RNAs?
Definite benefits of GLP-1 receptor agonists: what is the risk of gastroparesis and lung aspiration?
Large proximal gastric GIST tumours: downsizing by imatinib and subsequent endoresection
CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases
IQGAP3 signalling mediates intratumoral functional heterogeneity to enhance malignant growth
Withdrawal of antitumour necrosis factor in inflammatory bowel disease patients in remission: a randomised placebo-controlled clinical trial of GETECCU
Endoscopic papillectomy versus surgical ampullectomy for adenomas and early cancers of the papilla: a retrospective Pancreas2000/European Pancreatic Club analysis
TPX2 serves as a novel target for expanding the utility of PARPi in pancreatic cancer through conferring synthetic lethality
ECM1 attenuates hepatic fibrosis by interfering with mediators of latent TGF-β1 activation
Long-term hepatitis B surface antigen response after finite treatment of ARC-520 or JNJ-3989
Spatial single-cell profiling and neighbourhood analysis reveal the determinants of immune architecture connected to checkpoint inhibitor therapy outcome in hepatocellular carcinoma
Establishment of enterically transmitted hepatitis virus animal models using lipid nanoparticle-based full-length viral genome RNA delivery system
Emerging role of environmental pollutants in inflammatory bowel disease risk, outcomes and underlying mechanisms
Recent advances in incretin-based therapy for MASLD: from single to dual or triple incretin receptor agonists
Unravelling the obesity paradox in MASLD patients with extrahepatic cancer
Reassessing gastroscopy practices: the need for improved methodology and interpretation – author’s reply
Guidelines Development Group for the British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma
Morphological consistency between EUS and ERCP in diagnosing biliary sludge and microlithiasis
Sex-based differences in prescribed medications, surgical procedures and disease-related complications in IBD
Letter to the editor: Autoimmune gastritis may be less susceptible to cancer development than Helicobacter pylori-related gastritis based on histological analysis
